{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:54:09Z","timestamp":1792090449864,"version":"4.4.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"9","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Treatment of subarachnoid neurocysticercosis (NCC) is complicated, and assays that can guide treatment are not widely available. The reproducibility and scalability of molecular-based biomarkers would be of great use.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The Taenia solium genome was mined and primers and probes were designed to target repeats with the highest coverage; the most sensitive, specific, and efficient repeat (TsolR13) was selected for clinical testing. We tested 46 plasma samples and 36 cerebral spinal fluid (CSF) samples taken from patients with subarachnoid or ventricular disease using quantitative polymerase chain reaction (qPCR).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The analytic sensitivity of TsolR13 was 97.3% at 240 attograms (ag) of T. solium genomic DNA and 100% analytic specificity. The clinical sensitivity in detecting active subarachnoid or ventricular disease in symptomatic patients was 100% in CSF and 81.3% in plasma. The predictive ability to distinguish active from cured disease was better for CSF (94.4% of those cured had negative qPCR results) than for plasma (86.7% of those cured tested negative). Some subjects also had plasma DNA detectable intermittently for years after being cured. Overall, the test performance was equivalent to T. solium antigen detection.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>A qPCR test for the detection of the highly repetitive Tsol13 sequence has been developed and shown to be highly sensitive and specific for NCC, but also useful as a test of cure in CSF and for the definitive diagnosis of NCC in plasma.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciz541","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T21:35:59Z","timestamp":1561066559000},"page":"1875-1881","source":"Crossref","is-referenced-by-count":45,"title":["A Novel, Highly Sensitive Quantitative Polymerase Chain Reaction Assay for the Diagnosis of Subarachnoid and Ventricular Neurocysticercosis and for Assessing Responses to Treatment"],"prefix":"10.1093","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9425-2011","authenticated-orcid":false,"given":"Elise M","family":"O\u2019Connell","sequence":"first","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases (NIAID), Laboratory of Parasitic Diseases (LPD), Helminth Immunology Section, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Harrison","sequence":"first","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases (NIAID), Laboratory of Parasitic Diseases (LPD), Helminth Immunology Section, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Dahlstrom","sequence":"first","affiliation":[{"name":"NIAID, Research Technologies Branch, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore","family":"Nash","sequence":"first","affiliation":[{"name":"NIAID, LPD, Clinical Parasitology Section"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas B","family":"Nutman","sequence":"first","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases (NIAID), Laboratory of Parasitic Diseases (LPD), Helminth Immunology Section, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,6,21]]},"reference":[{"key":"2020041501054427700_CIT0001","volume-title":"WHO estimates of the global burden of foodborne diseases: foodborne disease burden epidemiology reference group 2007\u20132015","year":"2015"},{"key":"2020041501054427700_CIT0002","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/jcph.1346","article-title":"Factors associated with cysticidal treatment response in extraparenchymal neurocysticercosis","volume":"59","author":"Osorio","year":"2019","journal-title":"J Clin Pharmacol"},{"key":"2020041501054427700_CIT0003","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.4269\/ajtmh.18-0085","article-title":"Intraventricular neurocysticercosis: experience and long-term outcome from a tertiary referral center in the United States","volume":"98","author":"Nash","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"2020041501054427700_CIT0004","doi-asserted-by":"crossref","first-page":"945","DOI":"10.4269\/ajtmh.18-88751","article-title":"Diagnosis and treatment of neurocysticercosis: 2017 clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)","volume":"98","author":"White","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"2020041501054427700_CIT0005","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.actatropica.2015.08.017","article-title":"Relevance of 3D magnetic resonance imaging sequences in diagnosing basal subarachnoid neurocysticercosis","volume":"152","author":"Carrillo Mezo","year":"2015","journal-title":"Acta Trop"},{"key":"2020041501054427700_CIT0006","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1586\/eri.10.150","article-title":"Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease","volume":"9","author":"Fleury","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2020041501054427700_CIT0007","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1056\/NEJMp1408376","article-title":"High-cost generic drugs\u2013implications for patients and policymakers","volume":"371","author":"Alpern","year":"2014","journal-title":"N Engl J Med"},{"key":"2020041501054427700_CIT0008","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0020-7519(92)90148-E","article-title":"A monoclonal antibody-based ELISA for the detection of circulating excretory-secretory antigens in Taenia saginata cysticercosis","volume":"22","author":"Brandt","year":"1992","journal-title":"Int J Parasitol"},{"key":"2020041501054427700_CIT0009","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-3024.1989.tb00673.x","article-title":"Specific detection of circulating surface\/secreted glycoproteins of viable cysticerci in Taenia saginata cysticercosis","volume":"11","author":"Harrison","year":"1989","journal-title":"Parasite Immunol"},{"key":"2020041501054427700_CIT0010","doi-asserted-by":"crossref","first-page":"e2096","DOI":"10.1371\/journal.pntd.0002096","article-title":"Neurocysticercosis: HP10 antigen detection is useful for the follow-up of the severe patients","volume":"7","author":"Fleury","year":"2013","journal-title":"PLOS Negl Trop Dis"},{"key":"2020041501054427700_CIT0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4303\/jnp\/N100804","article-title":"Circulating antigen levels follow post-treatment evolution of subarachnoid neurocysticercosis","volume":"1","author":"Garcia","year":"2010","journal-title":"J Neuroparasitol"},{"key":"2020041501054427700_CIT0012","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1086\/597757","article-title":"Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis","volume":"199","author":"Rodriguez","year":"2009","journal-title":"J Infect Dis"},{"key":"2020041501054427700_CIT0013","doi-asserted-by":"crossref","first-page":"e0004578","DOI":"10.1371\/journal.pntd.0004578","article-title":"Improved PCR-based detection of soil transmitted helminth infections using a next-generation sequencing approach to assay design","volume":"10","author":"Pilotte","year":"2016","journal-title":"PLOS Negl Trop Dis"},{"key":"2020041501054427700_CIT0014","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin Chem"},{"key":"2020041501054427700_CIT0015","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1128\/JCM.05839-11","article-title":"Confirmation and follow-up of neurocysticercosis by real-time PCR in cerebrospinal fluid samples of patients living in France","volume":"49","author":"Yera","year":"2011","journal-title":"J Clin Microbiol"},{"key":"2020041501054427700_CIT0016","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/tmi.12089","article-title":"Bayesian modelling to estimate the test characteristics of coprology, coproantigen ELISA and a novel real-time PCR for the diagnosis of taeniasis","volume":"18","author":"Praet","year":"2013","journal-title":"Trop Med Int Health"},{"key":"2020041501054427700_CIT0017","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1472-765X.2010.02804.x","article-title":"A versatile internal control for use as DNA in real-time PCR and as RNA in real-time reverse transcription PCR assays","volume":"50","author":"Deer","year":"2010","journal-title":"Lett Appl Microbiol"},{"key":"2020041501054427700_CIT0018","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.meegid.2015.06.022","article-title":"Recent advances and perspectives in molecular epidemiology of Taenia solium cysticercosis","volume":"40","author":"Ito","year":"2016","journal-title":"Infect Genet Evol"},{"key":"2020041501054427700_CIT0019","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/qjmed\/hcp077","article-title":"Q fever: persistence of antigenic non-viable cell residues of Coxiella burnetii in the host\u2013implications for post Q fever infection fatigue syndrome and other chronic sequelae","volume":"102","author":"Marmion","year":"2009","journal-title":"QJM"},{"key":"2020041501054427700_CIT0020","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1128\/JCM.41.9.4435-4437.2003","article-title":"Streptococcus pneumoniae endocarditis: persistence of DNA on heart valve material 7 years after infectious episode","volume":"41","author":"Branger","year":"2003","journal-title":"J Clin Microbiol"},{"key":"2020041501054427700_CIT0021","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12917-017-0988-5","article-title":"Presence of Coxiella burnetii DNA in inflamed bovine cardiac valves","volume":"13","author":"Agerholm","year":"2017","journal-title":"BMC Vet Res"},{"key":"2020041501054427700_CIT0022","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.micinf.2004.06.006","article-title":"Molecular evidence of new variant brucella in North Pacific common minke whales","volume":"6","author":"Ohishi","year":"2004","journal-title":"Microbes Infect"},{"key":"2020041501054427700_CIT0023","doi-asserted-by":"crossref","first-page":"e0005115","DOI":"10.1371\/journal.pntd.0005115","article-title":"Clinical symptoms, imaging features and cyst distribution in the cerebrospinal fluid compartments in patients with extraparenchymal neurocysticercosis","volume":"10","author":"Bazan","year":"2016","journal-title":"PLOS Negl Trop Dis"},{"key":"2020041501054427700_CIT0024","doi-asserted-by":"crossref","first-page":"e2558","DOI":"10.1371\/journal.pntd.0002558","article-title":"High prevalence of cysticercosis in people with epilepsy in southern Rwanda","volume":"7","author":"Rottbeck","year":"2013","journal-title":"PLOS Negl Trop Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciz541\/29105317\/ciz541.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/70\/9\/1875\/33045522\/ciz541.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/70\/9\/1875\/33045522\/ciz541.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T05:06:19Z","timestamp":1586927179000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/70\/9\/1875\/5522280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,21]]},"references-count":24,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,6,21]]},"published-print":{"date-parts":[[2020,4,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciz541","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,5,1]]},"published":{"date-parts":[[2019,6,21]]}}}